{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:21:32Z","timestamp":1794856892356,"version":"4.9.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.resmer.2026.101260","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T06:12:18Z","timestamp":1772863938000},"page":"101260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Rheumatoid arthritis-associated interstitial lung disease: A review"],"prefix":"10.1016","volume":"89","author":[{"given":"Melanie","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Dieude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4814-0307","authenticated-orcid":false,"given":"Pierre-Antoine","family":"Juge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Pierre","family":"Debray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre LE","family":"Guen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Crestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Borie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.resmer.2026.101260_bib0001","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00296-017-3726-1","article-title":"Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014","volume":"37","author":"Hunter","year":"2017","journal-title":"Rheumatol Int"},{"issue":"160","key":"10.1016\/j.resmer.2026.101260_bib0002","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0011-2021","article-title":"Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management","volume":"30","author":"Kadura","year":"2021","journal-title":"Eur Respir Rev"},{"issue":"9","key":"10.1016\/j.resmer.2026.101260_bib0003","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2013a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatol (Oxf)"},{"issue":"6","key":"10.1016\/j.resmer.2026.101260_bib0004","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.resmer.2026.101260_bib0005","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/acr.25348","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.resmer.2026.101260_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2024.105790","article-title":"2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis","volume":"91","author":"Fautrel","year":"2024","journal-title":"Jt Bone Spine"},{"issue":"4583","key":"10.1016\/j.resmer.2026.101260_bib0007","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/bmj.2.4583.816","article-title":"Rheumatoid disease\u201d with joint and pulmonary manifestations","volume":"2","author":"Ellman","year":"1948","journal-title":"Br Med J"},{"issue":"2 Pt 1","key":"10.1016\/j.resmer.2026.101260_bib0008","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.resmer.2026.101260_bib0009","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med"},{"issue":"167","key":"10.1016\/j.resmer.2026.101260_bib0010","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0210-2022","article-title":"Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis","volume":"32","author":"Joy","year":"2023","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.resmer.2026.101260_bib0011","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1164\/rccm.202109-2087LE","article-title":"Prospective identification of subclinical interstitial lung disease in a rheumatoid arthritis cohort is associated with the MUC5B promoter variant","volume":"205","author":"Matson","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.resmer.2026.101260_bib0012","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.autrev.2013.05.001","article-title":"Lung involvement in connective tissue diseases: a comprehensive review and a focus on rheumatoid arthritis","volume":"12","author":"Marigliano","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"23","key":"10.1016\/j.resmer.2026.101260_bib0013","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B Promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.resmer.2026.101260_bib0014","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/art.1780401016","article-title":"Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review","volume":"40","author":"Kremer","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.resmer.2026.101260_bib0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10067-011-1758-6","article-title":"How common is methotrexate pneumonitis? A large prospective study investigates","volume":"31","author":"Sathi","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.resmer.2026.101260_bib0016","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/0003-4819-127-5-199709010-00003","article-title":"Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group","volume":"127","author":"Alarc\u00f3n","year":"1997","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.resmer.2026.101260_bib0017","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00005382-200310000-00004","article-title":"Methotrexate-induced pulmonary injury: serial CT findings","volume":"18","author":"Arakawa","year":"2003","journal-title":"J Thorac Imaging"},{"issue":"2","key":"10.1016\/j.resmer.2026.101260_bib0018","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1034\/j.1399-3003.2000.15b25.x","article-title":"Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients","volume":"15","author":"Imokawa","year":"2000","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.resmer.2026.101260_bib0019","first-page":"1164","article-title":"Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature","volume":"14","author":"Searles","year":"1987","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.resmer.2026.101260_bib0020","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/rheumatology\/keab552","article-title":"The attitudes and practices of physicians caring for patients with rheumatoid arthritis-associated interstitial lung disease: an international survey","volume":"61","author":"Solomon","year":"2022","journal-title":"Rheumatol"},{"issue":"4","key":"10.1016\/j.resmer.2026.101260_bib0021","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.38322","article-title":"Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials","volume":"66","author":"Conway","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.resmer.2026.101260_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028466","article-title":"Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts","volume":"9","author":"Kiely","year":"2019","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.resmer.2026.101260_bib0023","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/rheumatology\/41.3.262","article-title":"Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests","volume":"41","author":"Dawson","year":"2002","journal-title":"Rheumatol"},{"key":"10.1016\/j.resmer.2026.101260_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152031","article-title":"Methotrexate use reduces mortality risk in rheumatoid arthritis: a systematic review and meta-analysis of cohort studies","volume":"55","author":"Xu","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.resmer.2026.101260_bib0025","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00337-2020","article-title":"Methotrexate and rheumatoid arthritis associated interstitial lung disease","volume":"57","author":"Juge","year":"2021","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.resmer.2026.101260_bib0026","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejim.2013.07.004","article-title":"Rheumatoid arthritis (RA) associated interstitial lung disease (ILD)","volume":"24","author":"O\u2019Dwyer","year":"2013","journal-title":"Eur J Intern Med"},{"issue":"10","key":"10.1016\/j.resmer.2026.101260_bib0027","article-title":"The lung in rheumatoid arthritis: focus on interstitial lung disease","volume":"70","author":"P","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.resmer.2026.101260_bib0028","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","article-title":"Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction","volume":"14","author":"Holers","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.resmer.2026.101260_bib0029","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/rheumatology\/kel202","article-title":"Citrullination in extra-articular manifestations of rheumatoid arthritis","volume":"46","author":"Bongartz","year":"2007","journal-title":"Rheumatol"},{"issue":"5","key":"10.1016\/j.resmer.2026.101260_bib0030","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.semarthrit.2021.07.002","article-title":"MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression","volume":"51","author":"Juge","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.resmer.2026.101260_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106943","article-title":"Associations between shortened telomeres and rheumatoid arthritis-associated interstitial lung disease among U.S. Veterans","volume":"201","author":"Natalini","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.resmer.2026.101260_bib0032","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14532","article-title":"Cellular senescence mediates fibrotic pulmonary disease","volume":"8","author":"Schafer","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.resmer.2026.101260_bib0033","article-title":"Telomere dysfunction in idiopathic pulmonary fibrosis","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Med"},{"issue":"12","key":"10.1016\/j.resmer.2026.101260_bib0034","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3390\/jcm8122038","article-title":"Interstitial lung disease in rheumatoid arthritis remains a challenge for clinicians","volume":"8","author":"Bendstrup","year":"2019","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.resmer.2026.101260_bib0035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000502551","article-title":"Rheumatoid arthritis-associated interstitial Lung disease: clinical characteristics and predictors of mortality","volume":"98","author":"Hyldgaard","year":"2019","journal-title":"Respiration"},{"issue":"7","key":"10.1016\/j.resmer.2026.101260_bib0036","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10067-017-3707-5","article-title":"Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis","volume":"36","author":"Rojas-Serrano","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.resmer.2026.101260_bib0037","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.resmer.2026.101260_bib0038","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2214\/AJR.17.18384","article-title":"CT features of the usual interstitial pneumonia pattern: differentiating connective tissue disease-associated interstitial lung disease from idiopathic pulmonary fibrosis","volume":"210","author":"Chung","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.resmer.2026.101260_bib0039","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.resmer.2026.101260_bib0040","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/resp.12154","article-title":"Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung","volume":"18","author":"Antoniou","year":"2013","journal-title":"Respirology"},{"key":"10.1016\/j.resmer.2026.101260_bib0041","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaf133","article-title":"Value of lung ultrasonography for screening interstitial lung disease in patients with rheumatoid arthritis","author":"Ottaviani","year":"2025","journal-title":"Rheumatol"},{"issue":"5","key":"10.1016\/j.resmer.2026.101260_bib0042","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MCP.0000000000000710","article-title":"Recent advances in rheumatoid arthritis-associated interstitial lung disease","volume":"26","author":"Juge","year":"2020","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"10.1016\/j.resmer.2026.101260_bib0043","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02533-2020","article-title":"Two sides of the same coin? A review of the similarities and differences between idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease","volume":"57","author":"Matson","year":"2021","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.resmer.2026.101260_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103056","article-title":"Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease","volume":"21","author":"Akiyama","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.resmer.2026.101260_bib0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12890-023-02532-2","article-title":"Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"23","author":"Xie","year":"2023","journal-title":"BMC Pulm Med"},{"issue":"5","key":"10.1016\/j.resmer.2026.101260_bib0046","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02314-2016","article-title":"Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis","volume":"49","author":"Juge","year":"2017","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.resmer.2026.101260_bib0047","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/thorax-2023-220856","article-title":"Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional mendelian randomisation study","volume":"79","author":"Leavy","year":"2024","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.resmer.2026.101260_bib0048","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S2213-2600(22)00260-0","article-title":"Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study","volume":"11","author":"Solomon","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.resmer.2026.101260_bib0049","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.chest.2022.11.035","article-title":"Treatment outcomes for rheumatoid arthritis-associated interstitial lung disease: a real-world, multisite study of the impact of immunosuppression on pulmonary function trajectory","volume":"163","author":"Matson","year":"2023","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.resmer.2026.101260_bib0050","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.21037\/jtd-22-1820","article-title":"Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohort","volume":"15","author":"Marcoux","year":"2023","journal-title":"J Thorac Dis"},{"issue":"8","key":"10.1016\/j.resmer.2026.101260_bib0051","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/thx.56.8.622","article-title":"Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests","volume":"56","author":"Dawson","year":"2001","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.resmer.2026.101260_bib0052","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1183\/13993003.00357-2015","article-title":"Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease","volume":"47","author":"Solomon","year":"2016","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.resmer.2026.101260_bib0053","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/art.42640","article-title":"Identification, monitoring, and management of rheumatoid arthritis-associated interstitial lung disease","volume":"75","author":"Koduri","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.resmer.2026.101260_bib0054","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3390\/jcm10040874","article-title":"Predictors of progression and mortality in patients with prevalent rheumatoid arthritis and interstitial lung disease: a prospective cohort study","volume":"10","author":"Mena-V\u00e1zquez","year":"2021","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.resmer.2026.101260_bib0055","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2010.11.002","article-title":"Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases","volume":"41","author":"Perez-Alvarez","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.resmer.2026.101260_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(24)00265-0","article-title":"Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort study","volume":"7","author":"England","year":"2025","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.resmer.2026.101260_bib0057","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/rheumatology\/keab317","article-title":"Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis-multicentre study of 263 Caucasian patients","volume":"61","author":"Fern\u00e1ndez-D\u00edaz","year":"2021","journal-title":"Rheumatol"},{"issue":"12","key":"10.1016\/j.resmer.2026.101260_bib0058","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1093\/rheumatology\/keaa621","article-title":"Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients","volume":"59","author":"Fern\u00e1ndez-D\u00edaz","year":"2020","journal-title":"Rheumatol"},{"issue":"4","key":"10.1016\/j.resmer.2026.101260_bib0059","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/rheumatology\/keaa577","article-title":"Rheumatoid arthritis related interstitial lung disease - improving outcomes over 25 years: a large multicentre UK study","volume":"60","author":"Kelly","year":"2021","journal-title":"Rheumatol"},{"issue":"8","key":"10.1016\/j.resmer.2026.101260_bib0060","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/rheumatology\/kex072","article-title":"Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years\u2019 experience at a single centre","volume":"56","author":"Md Yusof","year":"2017","journal-title":"Rheumatol"},{"issue":"5","key":"10.1016\/j.resmer.2026.101260_bib0061","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.semarthrit.2020.08.008","article-title":"Real-world clinical effectiveness of rituximab rescue therapy in patients with progressive rheumatoid arthritis-related interstitial lung disease","volume":"50","author":"Narv\u00e1ez","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.resmer.2026.101260_bib0062","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000445031","article-title":"Usefulness of cyclophosphamide pulse therapy in interstitial lung diseases","volume":"91","author":"Schupp","year":"2016","journal-title":"Respiration"},{"issue":"9","key":"10.1016\/j.resmer.2026.101260_bib0063","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/imj.14670","article-title":"Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study","volume":"50","author":"Manfredi","year":"2020","journal-title":"Intern Med J"},{"issue":"3","key":"10.1016\/j.resmer.2026.101260_bib0064","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.3640","article-title":"Incidence of interstitial lung disease in patients with rheumatoid arthritis treated with biologic and targeted synthetic disease-modifying antirheumatic drugs","volume":"6","author":"Baker","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.resmer.2026.101260_bib0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S2213-2600(20)30036-9","article-title":"Nintedanib in patients with progressive fibrosing interstitial lung diseases\u2014Subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"8","author":"Wells","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.resmer.2026.101260_bib0066","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02533-2024","article-title":"ERS\/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease","volume":"67","author":"Antoniou","year":"2026","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.resmer.2026.101260_bib0067","first-page":"344","article-title":"Patterns of interstitial lung disease and mortality in rheumatoid arthritis","volume":"56","author":"Zamora-Legoff","year":"2017","journal-title":"Rheumatol"},{"issue":"3","key":"10.1016\/j.resmer.2026.101260_bib0068","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.resmer.2026.101260_bib0069","article-title":"Theory & practice of treat-to-target (T2T) in rheumatoid arthritis","volume":"39","author":"He","year":"2025","journal-title":"Best Pr Res Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.resmer.2026.101260_bib0070","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.42162","article-title":"A risk score to detect subclinical rheumatoid arthritis-associated interstitial lung disease","volume":"74","author":"Juge","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.resmer.2026.101260_bib0071","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.40904","article-title":"Rheumatoid arthritis disease activity predicting incident clinically apparent Rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study","volume":"71","author":"Sparks","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.resmer.2026.101260_bib0072","first-page":"501","article-title":"SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: treatment","volume":"18","author":"Narv\u00e1ez","year":"2022","journal-title":"Reum Clin Engl Ed"},{"issue":"5","key":"10.1016\/j.resmer.2026.101260_bib0073","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00408-013-9499-8","article-title":"Mycophenolate versus cyclophosphamide for progressive interstitial lung disease associated with systemic sclerosis: a 2-year case control study","volume":"191","author":"Panopoulos","year":"2013","journal-title":"Lung"},{"issue":"8","key":"10.1016\/j.resmer.2026.101260_bib0074","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatol"},{"issue":"2","key":"10.1016\/j.resmer.2026.101260_bib0075","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","article-title":"Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis","volume":"46","author":"Young","year":"2007","journal-title":"Rheumatol"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041226000152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041226000152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:13:03Z","timestamp":1780920783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041226000152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":75,"alternative-id":["S2590041226000152"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2026.101260","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatoid arthritis-associated interstitial lung disease: A review","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2026.101260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 SPLF and Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101260"}}